Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Cert. of designation
Director departure
SKYSTAR BIO-PHARMACEUTICAL CO (SKBI) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/15/2016 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
08/15/2016 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
04/28/2016 8-K/A Quarterly results
04/06/2016 8-K Form 8-K - Current report
01/11/2016 SC 13G/A SABBY MANAGEMENT, LLC reports a 2.8% stake in Skystar Bio-Pharmaceutical Company
06/02/2015 SC 13D/A SJ STRATEGIC INVESTMENTS LLC reports a 14.2% stake in Skystar Bio-Pharmaceutical Company
05/28/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
05/07/2015 4 GREGORY JOHN M (10% Owner) has filed a Form 4 on SKYSTAR BIO-PHARMACEUTICAL CO
04/20/2015 4 GREGORY JOHN M (10% Owner) has filed a Form 4 on SKYSTAR BIO-PHARMACEUTICAL CO
02/04/2015 SC 13D/A SJ STRATEGIC INVESTMENTS LLC reports a 12.4% stake in Skystar Bio-Pharmaceutical Company
02/03/2015 4 GREGORY JOHN M (10% Owner) has filed a Form 4 on SKYSTAR BIO-PHARMACEUTICAL CO
01/12/2015 SC 13G/A SABBY MANAGEMENT, LLC reports a 6.5% stake in Skystar Bio-Pharmaceutical Company
12/29/2014 4 GREGORY JOHN M (10% Owner) has filed a Form 4 on SKYSTAR BIO-PHARMACEUTICAL CO
12/15/2014 SC 13D/A GREGORY JOHN M reports a 11.2% stake in SKYSTAR BIO-PHARMACEUTICAL CO
12/11/2014 4 GREGORY JOHN M (10% Owner) has filed a Form 4 on SKYSTAR BIO-PHARMACEUTICAL CO
11/14/2014 10-Q Quarterly Report for the period ended September 30, 2014
11/13/2014 DEF 14A Form DEF 14A - Other definitive proxy statements:
08/14/2014 10-Q Quarterly Report for the period ended June 30, 2014
07/17/2014 SC 13G SABBY MANAGEMENT, LLC reports a 10% stake in Skystar Bio-Pharmaceutical Company
07/16/2014 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
05/28/2014 SC 13D/A SJ STRATEGIC INVESTMENTS LLC reports a 10% stake in Skystar Bio-Pharmaceutical Company
05/15/2014 10-Q Quarterly Report for the period ended March 31, 2014
04/15/2014 SC 13D/A SJ STRATEGIC INVESTMENTS LLC reports a 8.7% stake in Skystar Bio-Pharmaceutical Company
04/02/2014 SC 13D/A SJ STRATEGIC INVESTMENTS LLC reports a 7% stake in Skystar Bio-Pharmaceutical Company
03/31/2014 10-K Annual Report for the period ended December 31, 2013
03/24/2014 SC 13D SJ STRATEGIC INVESTMENTS LLC reports a 3.8% stake in Skystar Bio-Pharmaceutical Company
03/12/2014 4 Mei Bing (CFO) has filed a Form 4 on SKYSTAR BIO-PHARMACEUTICAL CO
03/12/2014 4 LU WEIBING (CEO) has filed a Form 4 on SKYSTAR BIO-PHARMACEUTICAL CO
12/04/2013 S-3 Form S-3 - Registration statement under Securities Act of 1933
11/14/2013 10-Q Quarterly Report for the period ended September 30, 2013
10/30/2013 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
09/27/2013 DEF 14A Form DEF 14A - Other definitive proxy statements
09/24/2013 SC 13G/A RENN Universal Growth Investment Trust reports a 4.9% stake in 8 Skystar Bio-Pharmaceutical Company
09/23/2013 SC 13G/A RENN Universal Growth Investment Trust reports a 5.1% stake in 7 Skystar Bio-Pharmaceutical Company
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy